News Search Results
Aug 04, 2025, 02:29 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics Anbogen Therapeutics is a clinical-stage biotechnology company committed to developing precision oncology therapies that improve the lives of cancer patients worldwide. The company currently has two
More news about: Anbogen Therapeutics
Aug 04, 2025, 02:29 ET Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease
Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing in its clinical trial of
More news about: Raytone Biotech
Aug 01, 2025, 16:01 ET AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 01, 2025, 13:01 ET Jewellok Unveils Cutting-Edge Specialty Gas Changeover Manifolds to Revolutionize Industrial and Medical Gas Delivery
advanced systems are engineered to provide a continuous and reliable gas supply for critical applications in industries such as semiconductors, biotechnology, pharmaceuticals, and renewable energy. With over a decade of experience in precision fluid management, Jewellok continues to deliver innovative
More news about: Shenzhen Jewellok Technology Co., Ltd
Aug 01, 2025, 11:23 ET Titan of Industry Allan Camaisa Teams Up with Res Nova Bio to Advance Breast Cancer Immunotherapy
Clinical Stage Biotechnology Company Uses Patient Immune System to "Seek and Destroy" Cancer and Metastasis SAN DIEGO, Aug. 1, 2025 /PRNewswire/
More news about: Res Nova Biologics, Inc.
Aug 01, 2025, 10:01 ET 3D Avatar Solution Market is Projected To Reach US$1,234.37 Million By 2031 Due To Significant Growth In E-Commerce And AI, ML, And Real-Time Rendering Innovations | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 01, 2025, 09:00 ET BioMarin Announces Appointment of Ian T. Clark to Board of Directors
Pharmaceuticals, Inc., Avrobio, Inc. and Kite Pharma, Inc. Mr. Clark is currently an advisor to KKR & Co. Inc., and previously served on the board of the Biotechnology Industry Organization, as well as a member of the 12th District Economic Advisory Council of the Federal Reserve. "We are very pleased to
More news about: BioMarin Pharmaceutical Inc.
Aug 01, 2025, 09:00 ET NeuroSense Provides Business Update and Progress for the First Half of 2025
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided business update with corporate highlights to date and
More news about: NeuroSense
Aug 01, 2025, 06:30 ET Chromatography Resin Market worth $4.94 billion by 2030 - Exclusive Report by MarketsandMarkets™
Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)), Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030", chromatography resin market size was USD 3.02 billion in 2024 and is projected
More news about: MarketsandMarkets
Aug 01, 2025, 03:52 ET Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease
Aug. 1, 2025 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biotechnology company focused on cellular energy restoration therapeutics, today announced the successful completion of its Phase I clinical trial for ENERGI-F705PD,
More news about: ENERGENESIS BIOMEDICAL CO., LTD.
Jul 31, 2025, 22:02 ET GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader
continue to push the boundaries and drive sustainable growth of the industry, aligning with our mission to 'Make People and Nature Healthier through Biotechnology'." The ongoing global recognition of GenScript's sustainability initiatives underscores its commitment to responsible business practices.
More news about: GenScript Biotech Corporation
Jul 31, 2025, 18:00 ET Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets
information and a PIN allowing them to access the live call. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Jul 31, 2025, 16:08 ET Human Longevity Extends $1M Cancer Pledge to Lung Cancer--Betting Big on AI-Driven Early Detection
https://www.humanlongevity.com/1mlung Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, AI, and multimodal diagnostics to extend human healthspan. Through its flagship Executive Health
More news about: Human Longevity, Inc.
Jul 31, 2025, 16:01 ET AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Jul 31, 2025, 13:55 ET QuantiPath Adds Top-Tier Executives to Leadership Team Ahead of GenoPATHx Launch
DENVER, July 31, 2025 /PRNewswire/ -- QuantiPath.bio, a biotechnology company redefining food safety through precision genetic diagnostics, today announced the addition of two accomplished professionals to its executive
More news about: QuantiPath
Jul 31, 2025, 13:35 ET MUSE Global School Opens in Santa Monica, Launching Vibrant New Chapter on the Westside
integration of MICA enhances the school's focus on individualized and collaborative learning. Whether diving into robotics, environmental science, or biotechnology, students can pursue their interests while developing tangible skills for the future. As Dr. Hunter advocates, MICA helps students "march across
More news about: MUSE Global School
Jul 31, 2025, 12:55 ET Tycko & Zavareei LLP: Cybersecurity Whistleblower receives $1.9 Million Reward of Nearly $10 Million False Claims Act Qui Tam Case Against a Biotechnology Company
Illumina, Inc., an American publicly traded biotechnology company, which develops and manufactures products related to genetic testing and research. A copy of the Whistleblower (Relator) Team's complaint
More news about: Tycko & Zavareei LLP
Jul 31, 2025, 10:45 ET Contract Research Organization Market is Poised to Reach USD 122.2 Billion by 2032 | SkyQuest Technology Consulting
chronic illnesses. The need for effective treatments is growing along with the number of chronic illnesses, which motivates pharmaceutical and biotechnology companies to develop new drugs.
More news about: SkyQuest Technology
Jul 31, 2025, 10:30 ET Cell Culture Market worth US$50.69 billion by 2030 with 11.2% CAGR | MarketsandMarkets™
users, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies' segment is estimated to register the highest growth rate during
More news about: MarketsandMarkets
Jul 31, 2025, 10:15 ET Biopharmaceuticals Market is Estimated to Reach USD 948.6 Bilion by 2032 | SkyQuest Technology Consulting
The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug development. Due to developments in gene therapies, vaccines, monoclonal antibodies, and next-generation biologics, treatment paradigms are shifting in a variety of therapeutic
More news about: SkyQuest Technology
Jul 31, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 31, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 31, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 31, 2025, 09:00 ET Mars doubles down on pursuit of perfect peanut, investing $5M in pioneering agri-science
University of Georgia Tifton Campus, HudsonAlpha Institute for Biotechnology and the USDA Agricultural Research Service (ARS).Develop disease-resistant peanut varieties in partnership with USDA ARS, HudsonAlpha Institute for Biotechnology and the National Institute of Agricultural Technology (INTA).Use
More news about: Mars, Incorporated
Jul 31, 2025, 07:44 ET AbbVie Reports Second-Quarter 2025 Financial Results
approved indications, and no new safety signals were identified in this study. AbbVie and Capstan Therapeutics, a clinical-stage biotechnology company dedicated to advancing in vivo engineering of cells through RNA delivery using targeted lipid nanoparticles (tLNPs), announced a definitive
More news about: AbbVie